Medical device maker Medtronic raises fiscal 2024 profit view

Reuters l device makers are seei annual her demand for their prod second ue to this year reco Tuesday surgical proce second-quarter e deferred during the pandemic, especially by older adults.

Medtronic joins medical device makers including Abbott Laboratories and Boston Scientific that have benefited from soaring demand for non-urgent surgeries.

The Dublin-based company reported a profit of $1.25 per share for the second quarter, above analysts' average estimat Medtronic class="summaryFeed_highLightText__NxlGi Abbott Laboratories > Boston Scientific yFeed_highLightText__NxlGi">Bengaluru Ch between $5.13 h 5.19 s="summaryFeed_ the fiscal year 2024 ">Khushi Mandowara5.08 5.16 ryFeed_highLightText__NxlGi">1.18 Dublin ed_highLightText__NxlGi">the second q 1.25 er